Member Directory

Myrio Therapeutics

Member Contact: Gouri Betigeri

Position: Head of Business Development

Industry: Biotech & Pharmaceuticals

Company Profile:

Myrio Therapeutics is a private biotechnology company, backed by a HNW family office; developing next-generation precision immunotherapies targeting oncogenic mutations using its proprietary peptide HLA binder technology. The company’s programs focus on delivering transformative therapies for solid tumors, leveraging its extensive antibody library and robust preclinical pipeline. For more on the company, please see: https://myriotx.com

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.